Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-01-23 12:51 pm Unchanged | 13G | CYNGN INC CYN | Empery Asset Management LP | 5,599,742 4.99% | 0 (Unchanged) | View |
| 2024-01-11 4:53 pm Purchase | 13G | TONIX PHARMACEUTICALS HLDG COM TNXP | Empery Asset Management LP | 55,675,674 9.99% | 55,675,674 (New Position) | View |
| 2024-01-11 3:55 pm Purchase | 13G | Volcon Inc. VCLN | Empery Asset Management LP | 21,080,129 9.99% | 21,080,129 (New Position) | View |
| 2024-01-10 09:00 am Purchase | 13G | CYNGN INC CYN | Empery Asset Management LP | 5,599,742 9.99% | 5,599,742 (New Position) | View |
| 2024-01-09 09:07 am Purchase | 13G | Elevation Oncology Inc. ELEV | Empery Asset Management LP | 4,000,000 6.7% | 4,000,000 (New Position) | View |
| 2024-01-09 09:06 am Purchase | 13G | SHARPS TECHNOLOGY INC STSS | Empery Asset Management LP | 5,315,986 9.99% | 5,315,986 (New Position) | View |
| 2024-01-09 09:05 am Purchase | 13G | SOBR SAFE INC SOBR | Empery Asset Management LP | 1,201,647 6.09% | 1,201,647 (New Position) | View |
| 2024-01-09 09:03 am Purchase | 13G | NUVVE HOLDING CORP WT EXP NVVEW | Empery Asset Management LP | 4,503,962 9.99% | 4,503,962 (New Position) | View |
| 2024-01-08 10:26 am Sale | 13G | X4 PHARMACEUTICALS INC XFOR | Empery Asset Management LP | 4,549,605 2.65% | -1,649,079 (-26.60%) | View |
| 2024-01-08 10:25 am Unchanged | 13G | Kiromic Biopharma Inc. KRBP | Empery Asset Management LP | 0 0% | 0 (Unchanged) | View |
| 2024-01-08 10:23 am Purchase | 13G | REDHILL BIOPHARMA LTD RDHL | Empery Asset Management LP | 259,129,600 3.19% | 259,129,600 (New Position) | View |
| 2024-01-08 10:22 am Purchase | 13G | Permex Petroleum Corp OILCF | Empery Asset Management LP | 52,083 4.99% | 52,083 (New Position) | View |
| 2023-01-13 08:04 am Purchase | 13G | REDHILL BIOPHARMA LTD RDHL | Empery Asset Management LP | 155,000,000 6.12% | 155,000,000 (New Position) | View |
| 2023-01-13 08:02 am Purchase | 13G | X4 PHARMACEUTICALS INC XFOR | Empery Asset Management LP | 6,198,684 5.12% | 6,198,684 (New Position) | View |
| 2023-01-13 08:00 am Purchase | 13G | Volcon Inc. VCLN | Empery Asset Management LP | 12,077,295 9.99% | 12,077,295 (New Position) | View |
| 2023-01-12 10:03 am Purchase | 13G | Permex Petroleum Corp OILCF | Empery Asset Management LP | 208,333 9.58% | 208,333 (New Position) | View |
| 2023-01-12 10:02 am Purchase | 13G | Kiromic Biopharma Inc. KRBP | Empery Asset Management LP | 4,898,044 9.99% | 4,898,044 (New Position) | View |
| 2023-01-12 10:01 am Unchanged | 13G | Direct Digital Holdings Inc. DRCT | Empery Asset Management LP | 270,000 4.99% | 0 (Unchanged) | View |
| 2023-01-12 10:01 am Sale | 13G | iSpecimen Inc. ISPC | Empery Asset Management LP | 437,500 4.68% | -28,833 (-6.18%) | View |
| 2022-03-18 5:15 pm Purchase | 13G | Direct Digital Holdings Inc. DRCT | Empery Asset Management LP | 270,000 9.64% | 270,000 (New Position) | View |